June 19, 2017
Biosimilar dev in US and EU

Biosimilar Regulatory Development in US and EU

As per the 2015 IMS report, the global biologics market is projected to reach 28% of the global pharmaceuticals market by 2020 [1]. This would translate to the biologics market potentially worth USD 390 billion in 2020. As many of the biologics will face patent expiration in the next 5 […]